Hence, these results indicate that the re-sensitisation of leptin signalling mediated by neutralising antibodies has a promising weight-lowering and thermogenic efficacy, thus making it a potential therapy against leptin-resistant obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.